- Home
- PRTS vs GRML Comparison
PRTS vs GRML Comparison
Compare PRTS & GRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRTS | GRML |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | N/A | 5 |
| Industry | Auto & Home Supply Stores | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.1M | 51.5M |
| IPO Year | 2006 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PRTS | GRML |
|---|---|---|
| Price | $0.65 | $0.34 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $0.50 | N/A |
| AVG Volume (30 Days) | 556.0K | ★ 2.9M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.25 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.37 | $0.27 |
| 52 Week High | $1.36 | $0.55 |
Technical Indicators
Market Signals| Indicator | PRTS | GRML |
|---|---|---|
| Relative Strength Index (RSI) | 25.79 | 37.01 |
| Support Level | $0.64 | $0.31 |
| Resistance Level | $0.75 | $0.43 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 3.22 | 2.62 |
Price Performance
Historical ComparisonAbout PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. Its products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About GRML Greenland Mines Ltd. Common Stock
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.